At its meeting the morning of Flag Day 2022, Beacon Angels members considered funding proposals from the following companies:
- Mr. Oleg Shikhman, CEO, Gynion—developing MenorrxTM treatment for Heavy Menstrual Bleeding (HMB), Menorrx is a safe and effective endometrial ablation therapy that is simpler, easier to use, and costs a fraction of the available alternatives;
- Mr. Jeff Lynch, CEO, presenting remotely regarding IdleSmart—offering a proprietary IoT solution for truck fleets to reduce yearly fuel costs of $10,000 per truck while increasing vehicle uptime and availability; and
- Mr. Doug Godfrin, CEO, who delivered an update on Veramorph, which reformulates generic drugs for oral efficacy and is co-developing a diverse portfolio of new drugs with a beachhead in the oral delivery of a drug treatment for metastatic breast cancer.
There followed a due diligence report on Pointz Mobility, a safety-focused mapping app that leverages crowdsourcing to help guide bike and scooter riders through pleasant, lower-stress routes in cities.
Members reported on the funding rounds of:
TopProp Fantasy, which has finalized the terms of its convertible note; and
Imago Rehab, which has accepted an extension of BA Series 99’s investment.
Members delivered company updates.